Ferrocenylchalcone-uracil conjugates: synthesis and cytotoxic evaluation

被引：6

作者：

Singh, Amandeep ^{[1
]}

Mehra, Vishu ^{[2
]}

Sadeghiani, Neda ^{[3
]}

Mozaffari, Saghar ^{[3
]}

Parang, Keykavous ^{[3
]}

Kumar, Vipan ^{[1
]}

机构：

[1] Guru Nanak Dev Univ, Dept Chem, Amritsar 143005, Punjab, India

[2] Hindu Coll, Dept Chem, Amritsar 143001, Punjab, India

[3] Chapman Univ, Sch Pharm, Ctr Targeted Drug Delivery, Irvine, CA 92618 USA

来源：

MEDICINAL CHEMISTRY RESEARCH | 2018年 / 27卷 / 04期

关键词：

Click chemistry; Cytotoxic evaluation; Ferrocenylchalcone; Uracil; ANTI-TUBERCULAR EVALUATION; BETA-LACTAM-FERROCENE; ANTICANCER AGENTS; CANCER; CELLS; DERIVATIVES; CHEMISTRY;

D O I：

10.1007/s00044-018-2145-5

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Huisgen's azide-alkyne cycloaddition reaction was employed to synthesize a series of 1H-1,2,3-triazole-tethered uracil-ferrocenyl chalcone conjugates with the aim of evaluating their in vitro anti-proliferative efficacy on human leukemia (CCRF-CEM) and human breast adenocarcinoma (MDA-MB-468) cell lines. Cytotoxic evaluation studies identified a number of synthesized conjugates that inhibited the proliferation of leukemia cancer cells by similar to 70% after 72 h. The selected synthesized conjugates were found to be significantly less cytotoxic against normal kidney cell line (LLC-PK1) when compared with CCRF-CEM cancer cells. [GRAPHICS] .

引用

页码：1260 / 1268

页数：9

共 28 条

[1] Development of organometallic (organo-transition metal) pharmaceuticals
Allardyce, CS
Dorcier, A
Scolaro, C
Dyson, PJ
[J]. APPLIED ORGANOMETALLIC CHEMISTRY, 2005, 19 (01) : 1 - 10
[2] [Anonymous], 2016, Cancer Facts Figures 2016, P1, DOI DOI 10.1097/01.NNR.0000289503.22414.79
[3] Molecular Mechanism of Action of 2-Ferrocenyl-1,1-diphenylbut-1-ene on HL-60 Leukemia Cells
de Oliveira, Alane Cabral
da Silva, Emanuella Gomes
Rocha, Danilo Damasceno
Hillard, Elizabeth A.
Pigeon, Pascal
Jaouen, Gerard
Rodrigues, Felipe A. R.
de Abreu, Fabiane C.
Ferreira, Fabricia da Rocha
Goulart, Marilia O. F.
Costa-Lotufo, Leticia V.
[J]. CHEMMEDCHEM, 2014, 9 (11) : 2580 - 2586
[4] DEZORMAZUR M, 1984, HETEROCYCLES, V22, P2739
[5] Synthesis of redox-active ferrocene pyrazole conjugates and their cytotoxicity in human mammary adenocarcinoma MCF-7 cells
Duivenvoorden, WCM
Liu , YN
Schatte, G
Kraatz, HB
[J]. INORGANICA CHIMICA ACTA, 2005, 358 (11) : 3183 - 3189
[6] Novel fluorinated acridone derivatives. Part 1: Synthesis and evaluation as potential anticancer agents
Fadeyi, Olugbeminiyi O.
Adamson, Saudat T.
Myles, E. Lewis
Okoro, Cosmas O.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4172 - 4176
[7] FERROCENYL POLYAMINES AS AGENTS FOR CHEMOIMMUNOTHERAPY OF CANCER
FIORINA, VJ
DUBOIS, RJ
BRYNES, S
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (04) : 393 - 395
[8] On the medicinal chemistry of ferrocene
Fouda, Mohammad F. R.
Abd-Elzaher, Mokhles M.
Abdelsamaia, Rafeek A.
Labib, Ammar A.
[J]. APPLIED ORGANOMETALLIC CHEMISTRY, 2007, 21 (08) : 613 - 625
[9] Therapeutic Protein Kinase Inhibitors
Grant, S. K.
[J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (07) : 1163 - 1177
[10] Hillard E, 2006, CHEMMEDCHEM, V1, P551, DOI [10.1002/cmdc.200500035, 10.1002/cmdc.20050035]

← 1 2 3 →